Stock Price
194.43
Daily Change
1.50 0.78%
Monthly
15.44%
Yearly
18.24%
Q4 Forecast
190.31

EPS Reference Time Actual Consensus Previous
2026-11-03 FY2026Q3 PM 2.44 2.10
2026-07-28 FY2026Q2 PM 2.46 2.17 1.89
2026-05-05 FY2026Q1 PM 1.73 1.66 1.68
2026-02-24 FY2025Q4 PM 2.17 1.95 1.90
2025-10-28 FY2025Q3 PM 2.10 1.89 1.68



Peers Price Chg Day Year Date
Acacia Research 4.33 -0.11 -2.48% 24.78% Oct/30
CBIZ 54.98 0 0% -0.04% Oct/30
Capita 256.50 -21.50 -7.73% -18.05% Oct/30
CRA International 196.08 -0.69 -0.35% 2.93% Oct/30
CoStar 30.17 2.03 7.21% -56.15% Oct/30
ExlService 41.43 0.31 0.75% 5.96% Oct/30
Exponent 80.26 1.95 2.49% 13.35% Oct/30
Franklin Covey 331.77 -14.70 -4.24% -0.04% Oct/30
FTI Consulting 182.84 1.60 0.88% 10.81% Oct/30
Fiserv 50.02 1.54 3.18% -25.00% Oct/30

Indexes Price Day Year Date
USND 25437 -747.73 -2.86% 7.22% Oct/30
US Index 2000 2812 -47.38 -1.66% 13.41% Oct/30

Huron Consulting traded at $194.43 this Friday October 30th, increasing $1.50 or 0.78 percent since the previous trading session. Looking back, over the last four weeks, Huron Consulting gained 15.44 percent. Over the last 12 months, its price rose by 18.24 percent. Looking ahead, we forecast Huron Consulting to be priced at 190.31 by the end of this quarter and at 178.46 in one year, according to Trading Economics global macro models projections and analysts expectations.

Huron Consulting Group Inc. is a global professional services firm. The Company offers solutions in operations, advisory services, technology and analytics. The Company's segments include Healthcare, Education and Life Sciences, and Business Advisory. Its Healthcare segment provides advisory services, from strategy setting through implementation, in the areas of organizational and resource alignment, clinical transformation, financial and operational performance, patient and caregiver engagement, and technology implementation and optimization. Its Education and Life Sciences segment provides management consulting and technology solutions to the higher education and academic medical centers, pharmaceutical and medical device, biotechnology and research industries. The Business Advisory segment's primary service lines include Enterprise Solutions and Analytics, and Business Advisory. The Business also enables clients to manage the data to optimize the operations and drive cloud adoption.